Pfizer has made a new and improved bid to acquire AstraZeneca with an offer worth £69.3 billion pounds ($116.6 billion) or £55 a share – and says this is its best and final offer for the firm. The US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback